Strategy

Novartis sets out its vision for pharma R&D

Read more

Light on the horizon for Swedish biopharma

Read more

Galecto raises €79 million in Series C round

Read more

Genmab looks ahead to next phase of growth

Read more

Targeting the genetic background of cancers

Read more

A small molecule approach to regenerative medicine

Read more

Calliditas makes debut on Nasdaq Stockholm

Read more

Building a culture of entrepreneurship in Nigeria

Read more

Organs-on-chips enter the laboratories of big pharma

Read more

The myth of biotech self-determination

Read more